Indevus Pharmaceuticals Inc.

(NASDAQ:IDEV)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Operating revenue
Total Revenue 23,330 20,419 17,643 16,398
Operating Revenue 23,330 20,419 17,643 16,398
Adjustments To Revenue — — — —
Cost Of Sales 9,459 6,520 5,262 4,786
Cost Of Sales With Depreciation 10,731 7,837 6,412 5,855
Gross Operating Profit 13,871 13,899 12,381 11,612
Operating Expenses
Research And Development Expenses 7,097 5,222 6,253 6,391
Selling General And Administrative Expenses 16,155 20,657 21,276 17,766
Advertising Expenses — — — —
Operating Income Before Depreciation -9,381 -11,980 -15,148 -12,545
Operating Income -10,741 -17,463 -16,795 -14,111
Depreciation 1,909 1,954 1,647 1,566
Depreciation Unreconciled — — — —
Amortization — — — —
Amortization Of Intangibles 637 637 497 497
Operating Income After Depreciation -11,290 -13,934 -16,795 -14,111
Non Operating Expenses
Interest Expense 3,594 1,891 1,761 1,712
Pre Tax Income -13,978 -18,964 -17,906 -14,703
Income Taxes — — — —
Minority Interest — — — —
Income Before Income Taxes — — — —
Net Income From Continuing Operations -13,978 -18,964 -17,906 -14,703
Net Income From Discontinued Operations — — — —
Net Income From Total Operations -13,978 -18,964 -17,906 -14,703
Non Recurring Events
Extraordinary Income Losses — — — —
Income From Cummulated Effect Of Accounting Changes — — — —
Income From Tax Loss Carryforward — — — —
Other Gains And Losses — — — —
Total Net Income -13,978 -18,964 -17,906 -14,703
Normalized Income -14,527 -15,435 -17,906 -14,703
NetIncome Available For Common -13,978 -18,964 -17,906 -14,703
Preferred Dividends — — — —
Excise Taxes — — — —